Erika Aldeguer

Statistics

Publications

Citations

592

H-Index

Active since

2017

Affiliations

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol(Current)

Instituto Oncológico Dr. Rosell

Institut Català d'Oncologia

USP Institut Universitari Dexeus

Hospital Universitario Dexeus

Erika Aldeguer is an author at Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol specializing in oncology, medicine, and molecular oncology.

Publications per year

2017–2022

Publications

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Niki Karachaliou, María González‐Cao, Guillermo Crespo et al. · Therapeutic Advances in Medical Oncology · 2018 · 274 citations · Full text

Medicine, Immunology, Oncology +17

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis

Niki Karachaliou, Imane Chaib, Andrés F. Cardona et al. · EBioMedicine · 2018 · 79 citations · Full text

Medicine, Cancer Biology, Oncology +12

Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non–Small-Cell Lung Cancer Patients

Noemı́ Reguart, Cristina Teixidó, Ana Giménez‐Capitán et al. · Clinical Chemistry · 2017 · 66 citations · Full text

Medicine, Molecular Biology, Oncology +17

Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)

Niki Karachaliou, Andrés F. Cardona, Jillian Wilhelmina Paulina Bracht et al. · EBioMedicine · 2018 · 44 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

David Carbone, Michael F. Sharpnack, Kai He et al. · Journal of Translational Medicine · 2018 · 28 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 11